Prostate Cancer Treatments: Are PSA Tests Overdone?
Much has been written over recent months about Prostate Cancer Treatments, particularly concerning studies showing that Prostate Specific Antigen (PSA) testing is counter-productive because the process identifies prostate cancer in younger men; causing many to have surgery or other, toxic treatments, unnecessarily.
That’s because prostate cancer is such a slow growing disease many men with it would otherwise live their full lives without knowing they ever had it.
The following article, from NaturalNews.com/ goes so far as to say one million men in the US may have been unnecessarily diagnosed and treated without any proper justification. Obviously, a situation which has not only inflated the prostate cancer statistics thereby distorting clinical reality but surely, it must have helped overwhelm hospital systems, also.
Wide-spread use of PSA tests are beneficial primarily only to urologists and oncologist and associated pathology testing laboratories, for whom PSA testing provides an even greater conveyor belt load of fee paying patients.
As for the individual patient, he may not get any benefit at all from the exercise. Just a life-changing experience that he will have to deal with for the rest of his life.
As an aside, I never place much stock in PSA tests in isolation, as there are far too many variables. They can only be considered in the context of other diagnostic tools.
Also, a recent study has show that contrary to surgeons pronouncing, as they do, that following surgery there is no sign of PSA, nanotechnology now evidences the presence of PSA not otherwise detectable. I’m not altogether sure of the significance of this but will endeavor to find out.
See the article at: Over A Million Men Overdiagnosed for Prostate Cancer, Treated Unnecessarily
Copyright ©2006